相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Direct stimulation of angiotensin II type 2 receptor enhances spatial memory
Fei Jing et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Irbesartan attenuates ischemic brain damage by inhibition of MCP-1/CCR2 signaling pathway beyond AT1 receptor blockade
Kana Tsukuda et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Effect of a centrally active angiotensin converting enzyme inhibitor, perindopril, on cognitive performance in chronic cerebral hypo-perfusion rats
Koji Yamada et al.
BRAIN RESEARCH (2011)
Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease
Yi-Fei Dong et al.
FASEB JOURNAL (2011)
Effect of Angiotensin II Type 2 Receptor Deletion in Hematopoietic Cells on Brain Ischemia-Reperfusion Injury
Jun Iwanami et al.
HYPERTENSION (2011)
Angiotensin II induces human astrocyte senescence through reactive oxygen species production
Gang Liu et al.
HYPERTENSION RESEARCH (2011)
The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia
Costantino Iadecola
ACTA NEUROPATHOLOGICA (2010)
Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease
Koji Yamada et al.
BRAIN RESEARCH (2010)
Remote control of brain angiotensin II levels by angiotensin receptor blockers
Masaki Mogi et al.
HYPERTENSION RESEARCH (2010)
Systemic candesartan reduces brain angiotensin II via downregulation of brain renin-angiotensin system
Nicolas Pelisch et al.
HYPERTENSION RESEARCH (2010)
Angiotensin II sustains brain inflammation in mice via TGF-β
Tobias V. Lanz et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis
Nien-Chen Li et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis
M. Kawajiri et al.
ACTA NEUROLOGICA SCANDINAVICA (2009)
Effects of valsartan on morbidity and mortality in uncontrolled hypertensive patients with high cardiovascular risks: KYOTO HEART Study
Takahisa Sawada et al.
EUROPEAN HEART JOURNAL (2009)
Aβ42-to-Aβ40-and Angiotensin-converting Activities in Different Domains of Angiotensin-converting Enzyme
Kun Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic
Zheng Gang Zhang et al.
LANCET NEUROLOGY (2009)
Angiotensin-converting enzyme (ACE) and ACE2 levels in the cerebrospinal fluid of patients with multiple sclerosis
M. Kawajiri et al.
MULTIPLE SCLEROSIS JOURNAL (2009)
Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system
Johannes Stegbauer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Exaggeration of Focal Cerebral Ischemia in Transgenic Mice Carrying Human Renin and Human Angiotensinogen Genes
Shinji Inaba et al.
STROKE (2009)
Attenuation of focal brain ischemia by telmisartan, an angiotensin II type 1 receptor blocker, in atherosclerotic apolipoprotein E-deficient mice
Masaru Iwai et al.
HYPERTENSION RESEARCH (2008)
Reduction of angiotensin II in the cerebrospinal fluid of patients with multiple sclerosis
M. Kowajiri et al.
MULTIPLE SCLEROSIS JOURNAL (2008)
Deletion of angiotensin II type 2 receptor attenuates protective effects of bone marrow stromal cell treatment on ischemia-reperfusion brain injury in mice
Jun Iwanami et al.
STROKE (2008)
Temporary pretreatment with the angiotensin II type 1 receptor blocker, valsartan, prevents ischemic brain damage through an increase in capillary density
Jian-Mei Li et al.
STROKE (2008)
Angiotensin II controls occludin function and is required for blood-brain barrier maintenance: Relevance to multiple sclerosis
Karolina Wosik et al.
JOURNAL OF NEUROSCIENCE (2007)
Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?
Patrick G. Kehoe et al.
LANCET NEUROLOGY (2007)
Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1
Jian-Mei Li et al.
MOLECULAR ENDOCRINOLOGY (2007)
Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study
Seibu Mochizuki et al.
LANCET (2007)
The calcium-channel blocker, azelnidipine, enhances the inhibitory action of AT1 receptor blockade on ischemic brain damage
Masaru Iwai et al.
JOURNAL OF HYPERTENSION (2006)
Comparison of inhibitory action of candesartan and enalapril on brain ischemia through inhibition of oxidative stress
Meiko Hamai et al.
NEUROPHARMACOLOGY (2006)
Physiology of local renin-angiotensin systems
Martin Paul et al.
PHYSIOLOGICAL REVIEWS (2006)
Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2
Masaki Mogi et al.
HYPERTENSION (2006)
Feasibility of treating prehypertension with an angiotensin-receptor blocker
S Julius et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes
PE Gallagher et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Amyloid β-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor
ML Hemming et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Angiotensin 2 type 2 receptor activity and ischemic stroke severity
B Ovbiagele et al.
NEUROLOGY (2005)
Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention -: Principal results of a prospective randomized controlled study (MOSES)
J Schrader et al.
STROKE (2005)
Angiotensin type 1 receptor block age improves ischemic injury following transient focal cerebral ischemia
N Hosomi et al.
NEUROSCIENCE (2005)
Angiotensin-converting enzyme inhibitors and incidence of Alzheimer's disease in Japan
T Ohrui et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2004)
Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation
M Iwai et al.
CIRCULATION (2004)
Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells
WB Strawn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2004)
Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist
YQ Wan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Cardiovascular and renal function of angiotensin II type-2 receptors
O Jöhren et al.
CARDIOVASCULAR RESEARCH (2004)
Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation
J Chalmers et al.
JOURNAL OF HYPERTENSION (2003)
Temocapril prevents motor neuron damage and upregulation of cydlooxygenase-II in glutamate-induced neurotoxicity
Y Iwasaki et al.
NEUROLOGICAL RESEARCH (2003)
Human marrow stromal cell therapy for stroke in rat - Neurotrophins and functional recovery
Y Li et al.
NEUROLOGY (2002)
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack (Vol 358, pg 1033, 2001)
LANCET (2001)
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
S MacMahon et al.
LANCET (2001)
Treatment of stroke in rat with intracarotid administration of marrow stromal cells
Y Li et al.
NEUROLOGY (2001)
The angiotensin converting enzyme (ACE) inhibitor, perindopril, modifies the clinical features of Parkinson's disease
KA Reardon et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE (2000)
Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice
Y Li et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2000)
分享论文
